SenesTech, Inc.(NASDAQ : SNES)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||7.10%||11.92||0.7%||$833.25m|
|VRTX||Vertex Pharmaceuticals, Inc.||2.52%||192.25||1.9%||$540.93m|
|GILD||Gilead Sciences, Inc.||1.30%||67.52||1.0%||$482.03m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.76%||539.14||2.7%||$392.93m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.57%||180.86||2.0%||$333.62m|
|EXAS||EXACT Sciences Corp.||-0.09%||130.85||18.1%||$175.89m|
|TXG||10X Genomics, Inc.||-2.02%||197.35||0.0%||$175.12m|
SenesTech, Inc. engages in the development and commercialization of a proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sector such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.